CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced that President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, June 4, 2014 at 9:30 a.m. Eastern Time. The conference is being held June 2-5 in New York City. CytRx Corporation (NASDAQ:CYTR) net profit margin is (not available %) and weekly performance is 15.47%. On last trading day company shares ended up $ 4.18. Analysts mean target price for the company is $ 11.00. CytRx Corporation (NASDAQ:CYTR) distance from 50-day simple moving average (SMA50) is 22.11%.
Sky-mobi Ltd (ADR) (NASDAQ:MOBI) (“Sky-mobi” or the “Company”), a leading mobile application platform in China, announced that the Company’s Board of Directors has approved a fiscal year-end change from March 31 to December 31, beginning in the calendar year ending December 31, 2014. Additionally, the Company also announced that its Board of Directors has approved a program to repurchase up to US$20 million of the Company’s American depositary shares (“ADSs”) over the next 12-month period, ending on May 30, 2015. Sky-mobi Ltd (ADR) (NASDAQ:MOBI) shares advanced 8.14% in last trading session and ended the day on $ 7.31. MOBI Gross Margin is 31.30 % and its return on assets is 3.90 %. Sky-mobi Ltd (ADR) (NASDAQ:MOBI) quarterly performance is 1.53%.
Hansen Medical, Inc. (NASDAQ:HNSN), a global leader in Intravascular Robotics, announced the successful completion of the first clinical procedures in the United States using the Magellan(TM) 6Fr Robotic Catheter. Alan Lumsden, MD, treated two patients with the 6Fr Catheter at Houston Methodist Hospital in Houston, TX. The cases included an endovascular aneurism repair (EVAR) to treat an abdominal aortic aneurysm and a lower extremity intervention for the treatment of peripheral artery disease. Hansen Medical, Inc. (NASDAQ:HNSN) shares moved up 5.76 % in last trading session and was closed at $ 1.47, while trading in range of $ 1.39 – $ 1.52. Hansen Medical, Inc. (NASDAQ:HNSN) year to date (YTD) performance is -15.03 %.
Analysts at Robert W. Baird initiated coverage on shares of Papa Murphy’s Holdings Inc (NASDAQ:FRSH) in a research note on Tuesday. They set an “outperform” rating and a $13.00 price target on the stock. Separately, analysts at Jefferies Group initiated coverage on shares of Papa Murphy’s Holdings in a research note on Tuesday. They set a “buy” rating and a $15.00 price target on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of Papa Murphy’s Holdings in a research note on Tuesday. They set an “outperform” rating on the stock. Five research analysts have rated the stock with a buy rating, Papa Murphy’s Holdings presently has a consensus rating of “Buy” and a consensus price target of $13.33. Papa Murphy’s Holdings Inc (NASDAQ:FRSH) ended the last trading day at $ 10.95. Company weekly volatility is calculated as 6.31 % and price to cash ratio as 50.22. Papa Murphy’s Holdings Inc (NASDAQ:FRSH) showed a positive weekly performance of 20.99 %.
Oramed Pharmaceuticals, Inc. (NASDAQ:RMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has been added to the Morgan Stanley Capital International (MSCI) MicroCap Index, effective as of market close on May 30, 2014. Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) net profit margin is (not available) % and weekly performance is -11.19 %. On last trading day company shares ended up $ 8.33. Analysts mean target price for the company is $ 31.00. Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) distance from 50-day simple moving average (SMA50) is -22.21 %.
Leave a Reply